Skip to main content
SpringerLink
Log in

Zerebral metastasiertes Mammakarzinom

Temozolomid: Keine Radiosensibilisierung bei Brustkrebs mit Hirnmetastasen

  • journal club
  • Published:
Info Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Originalie

  • Cao KI et al. Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer. Ann Oncol. 2015;26(1): 89-94.

Download references

Author information

Authors and Affiliations

  1. Klinik für Neurologie, Universitätsspital Zürich, Zürich, Schweiz

    Michael Weller (Direktor)

Authors
  1. Michael Weller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Weller.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weller, M. Temozolomid: Keine Radiosensibilisierung bei Brustkrebs mit Hirnmetastasen. Info Onkol. 18, 19 (2015). https://doi.org/10.1007/s15004-015-0763-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-015-0763-3

Schlüsselwörter

Search

Navigation